Companies covered: Danaher Corporation (NYSE:DHR), Avantor Inc. (NYSE:AVTR), Agilent Technologies, Inc. (NYSE:A), EXACT Sciences Corporation (NASDAQ:EXAS), PerkinElmer, Inc. (NYSE:PKI), Thermo Fisher Scientific Inc (NYSE:TMO), Abbott Laboratories (NYSE:ABT), Hologic, Inc. (NASDAQ:HOLX), Novocure Ltd. (NASDAQ:NVCR), Illumina, Inc. (NASDAQ:ILMN), Johnson & Johnson (NYSE:JNJ), Medtronic, Inc. (NYSE:MDT), Edwards Lifesciences Corporation (NYSE:EW), Quidel Corporation (NASDAQ:QDEL), Intuitive Surgical, Inc. (NASDAQ:ISRG), Ortho Clinical Diagnostics Holdings PLC (NASDAQ:OCDX), PPD Inc. (NASDAQ:PPD), DexCom, Inc. (NASDAQ:DXCM), Zimmer Biomet Holdings Inc. (NYSE:ZBH), Tandem Diabetes Care, Inc. (NASDAQ:TNDM), Stryker Corporation (NYSE:SYK), Glaukos Corp (NYSE:GKOS), Cooper Companies, Inc. (The) (NYSE:COO), Insulet Corporation (NASDAQ:PODD), Inogen, Inc (NASDAQ:INGN), Sientra, Inc. (NASDAQ:SIEN), Boston Scientific Corporation (NYSE:BSX), Koninklijke Philips N.V. (NYSE:PHG), Irhythm Technologies Inc. (NASDAQ:IRTC), Soliton Inc. (NASDAQ:SOLY), Neuronetics Inc. (NASDAQ:STIM), Eargo Inc. (NASDAQ:EAR), electroCore, Inc. (NASDAQ:ECOR), IsoRay, Inc. (NYSEAMERICAN:ISR), ReWalk Robotics Ltd (NASDAQ:RWLK), Sensus Healthcare (NASDAQ:SRTS)
